Cross‐sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease

INTRODUCTION: This study examined plasma glial fibrillary acidic protein (GFAP) as a biomarker of cognitive impairment due to Alzheimer's disease (AD) with and against plasma neurofilament light chain (NfL), and phosphorylated tau (p‐tau)(181+231). METHODS: Plasma samples were analyzed using Si...

Descripción completa

Detalles Bibliográficos
Autores principales: Ally, Madeline, Sugarman, Michael A., Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J., Karikari, Thomas K., Aparicio, Hugo J., Frank, Brandon, Tripodis, Yorghos, Martin, Brett, Palmisano, Joseph N., Steinberg, Eric G., Simkin, Irene, Farrer, Lindsay A., Jun, Gyungah R., Turk, Katherine W., Budson, Andrew E., O'Connor, Maureen K., Au, Rhoda, Goldstein, Lee E., Kowall, Neil W., Killiany, Ronald, Stern, Robert A., Stein, Thor D., McKee, Ann C., Qiu, Wei Qiao, Mez, Jesse, Alosco, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599277/
https://www.ncbi.nlm.nih.gov/pubmed/37885919
http://dx.doi.org/10.1002/dad2.12492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599277/
https://www.ncbi.nlm.nih.gov/pubmed/37885919
http://dx.doi.org/10.1002/dad2.12492

Ejemplares similares